967 resultados para AH plus
Resumo:
ECUADORIAN CLEANER SERVICES CLEANER PLUS S.A. Es una empresa que se ha propuesto alcanzar varios objetivos en el actual Directorio conformado por Félix Marín Rueda, Presidente Ejecutivo, y Jorge Lagla Salazar, Gerente General; a pesar de que la empresa no cuenta con una Planificación estratégica como tal, sin embargo sus fines se enmarcan en planes a corto, mediano y largo plazo, los mismos que para llevarse a cabo necesitan de forma inmediata que todos los procesos de la empresa se encuentren formalizados. Uno de los principales problemas que tiene la empresa, y en el cual se sustenta la aplicación del presente proyecto, radica en la falta de un manual de procesos específicos, ya que todas las actividades actualmente se están llevando de forma empírica, lo que dificulta el actuar empresarial de Cleaner Plus S.A. evidenciando la inexistencia de planificación, organización y coordinación interna entre todas las áreas de la empresa.
Resumo:
In this thesis we consider Wiener-Hopf-Hankel operators with Fourier symbols in the class of almost periodic, semi-almost periodic and piecewise almost periodic functions. In the first place, we consider Wiener-Hopf-Hankel operators acting between L2 Lebesgue spaces with possibly different Fourier matrix symbols in the Wiener-Hopf and in the Hankel operators. In the second place, we consider these operators with equal Fourier symbols and acting between weighted Lebesgue spaces Lp(R;w), where 1 < p < 1 and w belongs to a subclass of Muckenhoupt weights. In addition, singular integral operators with Carleman shift and almost periodic coefficients are also object of study. The main purpose of this thesis is to obtain regularity properties characterizations of those classes of operators. By regularity properties we mean those that depend on the kernel and cokernel of the operator. The main techniques used are the equivalence relations between operators and the factorization theory. An invertibility characterization for the Wiener-Hopf-Hankel operators with symbols belonging to the Wiener subclass of almost periodic functions APW is obtained, assuming that a particular matrix function admits a numerical range bounded away from zero and based on the values of a certain mean motion. For Wiener-Hopf-Hankel operators acting between L2-spaces and with possibly different AP symbols, criteria for the semi-Fredholm property and for one-sided and both-sided invertibility are obtained and the inverses for all possible cases are exhibited. For such results, a new type of AP factorization is introduced. Singular integral operators with Carleman shift and scalar almost periodic coefficients are also studied. Considering an auxiliar and simpler operator, and using appropriate factorizations, the dimensions of the kernels and cokernels of those operators are obtained. For Wiener-Hopf-Hankel operators with (possibly different) SAP and PAP matrix symbols and acting between L2-spaces, criteria for the Fredholm property are presented as well as the sum of the Fredholm indices of the Wiener-Hopf plus Hankel and Wiener-Hopf minus Hankel operators. By studying dependencies between different matrix Fourier symbols of Wiener-Hopf plus Hankel operators acting between L2-spaces, results about the kernel and cokernel of those operators are derived. For Wiener-Hopf-Hankel operators acting between weighted Lebesgue spaces, Lp(R;w), a study is made considering equal scalar Fourier symbols in the Wiener-Hopf and in the Hankel operators and belonging to the classes of APp;w, SAPp;w and PAPp;w. It is obtained an invertibility characterization for Wiener-Hopf plus Hankel operators with APp;w symbols. In the cases for which the Fourier symbols of the operators belong to SAPp;w and PAPp;w, it is obtained semi-Fredholm criteria for Wiener-Hopf-Hankel operators as well as formulas for the Fredholm indices of those operators.
Resumo:
In traditional criminal investigation, uncertainties are often dealt with using a combination of common sense, practical considerations and experience, but rarely with tailored statistical models. For example, in some countries, in order to search for a given profile in the national DNA database, it must have allelic information for six or more of the ten SGM Plus loci for a simple trace. If the profile does not have this amount of information then it cannot be searched in the national DNA database (NDNAD). This requirement (of a result at six or more loci) is not based on a statistical approach, but rather on the feeling that six or more would be sufficient. A statistical approach, however, could be more rigorous and objective and would take into consideration factors such as the probability of adventitious matches relative to the actual database size and/or investigator's requirements in a sensible way. Therefore, this research was undertaken to establish scientific foundations pertaining to the use of partial SGM Plus loci profiles (or similar) for investigation.
Resumo:
To assess the impact of admission to different hospital types on early and 1-year outcomes in patients with acute coronary syndrome (ACS). Between 1997 and 2009, 31 010 ACS patients from 76 Swiss hospitals were enrolled in the AMIS Plus registry. Large tertiary institutions with continuous (24 hour/7 day) cardiac catheterisation facilities were classified as type A hospitals, and all others as type B. For 1-year outcomes, a subgroup of patients admitted after 2005 were studied. Eleven type A hospitals admitted 15987 (52%) patients and 65 type B hospitals 15023 (48%) patients. Patients admitted into B hospitals were older, more frequently female, diabetic, hypertensive, had more severe comorbidities and more frequent non-ST segment elevation (NSTE)-ACS/unstable angina (UA). STE-ACS patients admitted into B hospitals received more thrombolysis, but less percutaneous coronary intervention (PCI). Crude in-hospital mortality and major adverse cardiac events (MACE) were higher in patients from B hospitals. Crude 1-year mortality of 3747 ACS patients followed up was higher in patients admitted into B hospitals, but no differences were found for MACE. After adjustment for age, risk factors, type of ACS and comorbidities, hospital type was not an independent predictor of in-hospital mortality, in-hospital MACE, 1-year MACE or mortality. Admission indicated a crude outcome in favour of hospitalisation during duty-hours while 1-year outcome could not document a significant effect. ACS patients admitted to smaller regional Swiss hospitals were older, had more severe comorbidities, more NSTE-ACS and received less intensive treatment compared with the patients initially admitted to large tertiary institutions. However, hospital type was not an independent predictor of early and mid-term outcomes in these patients. Furthermore, our data suggest that Swiss hospitals have been functioning as an efficient network for the past 12 years.
Resumo:
The widespread incidence of enterococci resistant to ampicillin, vancomycin and aminoglycosides, the first-line anti-enterococcal antibiotics, has made the treatment of severe enterococcal infections difficult and alternatives should be explored. We investigated the activity of daptomycin combined with linezolid against three Enterococcus faecalis and four Enterococcus faecium strains resistant to standard drugs used for therapy. Minimum inhibitory concentrations (MICs) were determined by the broth dilution method. Drug interactions were assessed by the checkerboard and time-kill methods. Synergy was defined by a fractional inhibitory concentration index (FICI) of ≤0.5 or a ≥2 log10 CFU/mL killing at 24 h with the combination in comparison with killing by the most active single agent. Indifference was defined by a FICI > 0.5-4.0 or a 1-2 log10 CFU/mL killing compared with the most active single agent. MICs of daptomycin were 2-4 μg/mL for E. faecalis and 2-8 μg/mL for E. faecium. MICs of linezolid were 1-2 μg/mL for all bacteria. In the checkerboard assay, five isolates showed synergism (FICI < 0.5) and two showed indifference (FICIs of 0.53 and 2). Killing studies revealed synergy of daptomycin plus linezolid against four isolates (2.2-3.7 log10 CFU/mL kill) and indifference (1.1-1.6 log10 CFU/mL kill) for the other three strains. Antagonism was not observed. In conclusion, the combination of daptomycin and linezolid had a synergistic or indifferent effect against multidrug-resistant enterococci. Additional studies are needed to explore the potential of this combination for severe enterococcal infections when first-line antibiotic combinations cannot be used.
Resumo:
1830/10 (T48)-1830/12.
Resumo:
1828/07 (T39)-1828/09.
Resumo:
1832/10 (T56)-1832/12.
Resumo:
1827/01 (T33)-1827/03.